9th Annual
Biotech in Europe Investor Forum
14-15 September 2009 • SIX Swiss Exchange, Zurich
Our Annual European event for investing in Biotech will once again be held in Zurich and will feature our core sponsors & partners and an audience of over 300 investors, analysts & media.
The forum will provide presenting opportunities for over 60 public & private companies. View Companies presenting at the Forum.
Day one will start with plenary presentations to be followed by a networking lunch. The afternoon sessions comprise investment and partnering-focused tracks hosted by speakers from Eli Lilly, Merck & Co., Merck Serono, Novartis, and Roche.
The second day of the forum will feature 2 tracks of presentations from publicly and privately funded companies from Europe, Australia and North America. View full Agenda.
The forum will host a networking dinner on the evening of the 14th September for the DyoDelta Innovation Awards.
We already have delegates attending from a wide range of companies and organisations. View Companies and Organisations.
More details to follow. Please check this website for regular updates.
Presenting at the forum offers excellent opportunities to showcase your company to some of the leading global investors and corporates. It will offer you the opportunity to communicate your projected capital raising plans or simply help you in finding the right partner for your business.
Presenting companies from Europe and the US will benefit from specially designed panels and keynote addresses from leading industry figures as well as access to some of the leading analysts and investors from Europe and beyond. This year, we aim to expand the audience and provide once again, opportunities for executive-level networking, deal-making and strategic partnering.
The 2008 event was fully sold out – don’t miss out on your opportunity to join us in Zurich and showcase your company to an audience of investors, money managers, VC’s and fund managers. Click here to see the list of 08 presenters >>>
The forum is recognised as the leading international stage for those interested in investing in the biotech and life science industry and is highly transactional, drawing together an exciting cross-section of early-stage/pre-IPO, late-stage and public companies with leading investors, analysts, money managers and pharmas. Supported and designed by leading figures within Europe’s bio industry, this event will once again be covered by our regular media partners.
Sachs Associates has developed an extensive knowledge of the key individuals operating within the European and global biotech industry. This together with a growing reputation for excellence puts Sachs Associates at the forefront of the industry and provides a powerful tool by which to increase the position of your company in this market.
Raise your company’s profile directly with your potential clients. All of our sponsorship packages are tailor made to each client, allowing your organisation to gain the most out of attending our industry driven events.
To learn more about sponsorship & presenting opportunities, please contact Deborah Hausman+ 44 20 7405 5579 or by email